Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects

This publication has 39 references indexed in Scilit:

• H2AX: A key player in DNA damage response and a promising target for cancer therapy
  Biomedicine & Pharmacotherapy, 2024
• A quantitative model for virus uncoating predicts influenza A infectivity
  Cell Reports, 2023
• Positive and negative regulators of RAD51/DMC1 in homologous recombination and DNA replication
  DNA Repair, 2023
• Oxidative stress-induced apoptosis and autophagy: Balancing the contrary forces in spermatogenesis
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
• Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras
  2022
• Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways
  Cell Reports, 2022
• Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
  Archives of Toxicology, 2021
• Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
  International Journal of Cancer, 2019
• Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells
  Archives of Toxicology, 2016
• How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot
  2016